Stockreport

Are Investors Undervaluing Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) By 30%? [Yahoo! Finance]

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com
PDF Current share price of US$35.63 suggests Ionis Pharmaceuticals is potentially 30% undervalued Our fair value estimate is 17% lower than Ionis Pharmaceuticals' analyst [Read more]